Camlin Fine Sciences Ltd
NSE:CAMLINFINE

Watchlist Manager
Camlin Fine Sciences Ltd Logo
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
Watchlist
Price: 106.47 INR -0.46% Market Closed
Market Cap: ₹20.5B

Camlin Fine Sciences Ltd
Investor Relations

Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.

Show more
Loading
CAMLINFINE
BSE Sensex 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 13, 2026
AI Summary
Q3 2026

Revenue Growth: Q3 turnover was INR 572 crores, flat sequentially but up 6% YoY.

Vanillin Sales: Vanillin volumes were intentionally held back this quarter to benefit from upcoming US tariff reductions, with improved realizations expected in Q4 and next year.

Margin Outlook: Gross margin for the quarter was 45.8%, slightly down due to price pressure in the ingredients business. Company guides for gross margins to rise to 46-47% and EBITDA margins to reach 12-14% in FY '27.

Blends Growth: Blends business grew by 11-13% YoY, boosted by the Vinpai acquisition, and is guided to continue strong growth.

Operational Challenges: A major fire at the Brazil blending unit caused inventory loss (INR 32.7 crores), but insurance is expected to cover most losses; short-term margin impact anticipated.

Restructuring: European and China operations are being liquidated, which will stem ongoing cash losses.

Guidance: FY '27 revenue guidance set at INR 2,200 crores, with Vanillin volume target of 4,000 tonnes and Blends expected to grow 25%.

Key Financials
Revenue
INR 572 crores
Vanillin Sales Volume
1,740 metric tons (first 9 months FY '26)
Gross Margin
45.8%
EBITDA Margin
around 7% (exact figure not fully specified)
Blends Revenue
INR 271 crores (Q3)
Ingredient (Straits) Revenue
INR 80 crores (Q3)
Vinapi Monthly Revenue Run Rate
INR 12.5–13 crores
Inventory Loss from Brazil Fire
INR 28 crores (inventory), INR 32.7 crores (total book value)
Earnings Call Recording
Other Earnings Calls

Management

Mr. Ashish Subhash Dandekar
Chairman & MD
No Bio Available
Mr. Arjun Sudhakar Dukane
Executive Director of Technical & Executive Director
No Bio Available
Mr. Nirmal Vinod Momaya
MD & Director
No Bio Available
Mr. Santosh L. Parab
Chief Financial Officer
No Bio Available
Mr. Nilesh Jadhav
Chief Operating Officer
No Bio Available
Mr. Rahul D. Sawale
Company Secretary, Compliance Officer & VP of Legal
No Bio Available
Jatin Gohil
Senior General Manager of Sales & Business Development
No Bio Available
Amarsinh Jadhavrao
Chief Executive of HR & Corporate Affairs
No Bio Available
Raghunath Bal
Global Head of IT
No Bio Available
Ms. Rajani Subhash Dandekar B.A.
Management Consultant
No Bio Available

Contacts

Address
MAHARASHTRA
Mumbai
F/11 & 12, Wicel, Opp. SEEPZ Main Gate, Andheri (East)
Contacts
+912267001000
www.camlinfs.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett